SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.…
Synbiotic SE Aktie: Kurs, Chart, News und Analyse
SynBiotic (ETR: SBX) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 79 employees.
The shares were at 0.1146 EUR on 20 November 2026, down 94.4% over 52 weeks. Its 52-week range is 0.1000 EUR to 3.845 EUR: the price is 97.0% below the high and 14.6% above the low.
Its market capitalisation is 833.14K EUR.
SynBiotic reports return on equity of -42.5% and an operating margin of -22.0%.
Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.